SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-463599
Filing Date
2013-12-05
Accepted
2013-12-05 16:30:35
Documents
4
Period of Report
2013-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d638209d8k.htm 8-K 15325
2 EX-99.1 d638209dex991.htm EX-99.1 7960
3 EX-99.2 d638209dex992.htm EX-99.2 7622
4 GRAPHIC g638209g82c54.jpg GRAPHIC 3927
  Complete submission text file 0001193125-13-463599.txt   37763
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 131260190
SIC: 2835 In Vitro & In Vivo Diagnostic Substances